From the perspective of signaling pathways, mainstream research indicates that glutamine addiction is associated with the progression and metastasis of prostate cancer cells through three distinct pathways: the AR pathway, the MYC pathway, and the PTEN/PI3K/mTOR pathway. The gene discussed is AR; the disease is prostate cancer.